5.4 Social Anxiety Disorder – Diagnostic Criteria, Epidemiology, Etiology & Treatment

DSM-5 Diagnostic Criteria for Social Anxiety Disorder (Social Phobia)

  • Core feature: Marked fear or anxiety about one or more social situations in which the individual may be scrutinized, evaluated, or judged by others.
    • Typical situations:
    • Conversations, meeting unfamiliar people, dating, interviews.
    • Being observed eating or drinking.
    • Performing in public (e.g., giving a speech).
  • Children-specific requirement: Anxiety must occur in peer settings, not only with adults.
  • Criterion B – Fear of negative evaluation:
    • Person worries they will act in a way, or display symptoms, that will be humiliating, embarrassing, offensive, or lead to rejection.
  • Criterion C – Social situations almost always provoke fear/anxiety.
    • In children, may manifest as crying, tantrums, freezing, clinging, shrinking, or failing to speak.
  • Criterion D – Situations are avoided, or endured with intense fear/anxiety.
  • Criterion E – Fear/anxiety is out of proportion to the actual threat and to socio-cultural context.
  • Criterion F – Persistence: typically 6\ge 6 months.
  • Criterion G – Causes clinically significant distress or impairment in social, occupational, or other important areas.
  • Criterion H – Not attributable to physiological effects of a substance or another medical condition.
  • Criterion I – Not better explained by another mental disorder (e.g., panic disorder, body-dysmorphic disorder, autism spectrum disorder).
  • Criterion J – If a separate medical condition is present (e.g., obesity, disfigurement, burns), the fear is clearly unrelated or excessive.
  • Specifier – “Performance only”: Anxiety is restricted to speaking/performing in public (e.g., public speaking).

Epidemiology & Demographics

  • Lifetime prevalence: 12%12\% of the general population.
  • Sex ratio: ~60%60\% of diagnosed cases are women.
  • Typical age of onset: Early adolescence to early adulthood.

Comorbidity & Functional Impact

  • Anxiety disorders: Nearly 23\tfrac{2}{3} of individuals have ≥1 additional anxiety disorder across the lifespan.
  • Depressive disorders: ≈50%50\% have a concurrent depressive disorder.
  • Alcohol use: ≈13\tfrac{1}{3} abuse alcohol, often as self-medication before social events ("liquid courage").
  • Employment & SES: On average, lower employment rates, lower socioeconomic status; ≈13\tfrac{1}{3} show severe impairment in ≥1 life domain.
  • Course: Highly persistent; only ≈13\tfrac{1}{3} recover spontaneously over 1212 years (vs. higher spontaneous-recovery rates in disorders such as major depression).
  • Network perspective: Comorbid patterns (e.g., anxiety + alcohol use) suggest overlapping causal networks rather than fully independent “diseases.”

Etiology: Psychological Factors

  • Classical conditioning
    • Direct trauma: Being the target of anger, criticism, or humiliation can serve as an unconditioned stimulus that pairs social cues with fear.
    • Two studies: 5658%56{-}58\% of those with social anxiety recalled a direct traumatic social experience at onset (Augustine & H. Ø. 1981; Townley et al., 1995).
    • Vicarious conditioning: Observing others being criticized/humiliated can also trigger learning.
    • Laboratory evidence: Fear conditioning is stronger when conditioned stimuli are social (critical face, harsh words) vs. nonsocial (bad odor, pressure pain).
  • Childhood teasing/bullying
    • 92%92\% of adults with social anxiety reported severe childhood teasing vs. 35%35\% of an OCD comparison group (McCabe et al., 2003).

Etiology: Biological & Temperamental Factors

  • Behavioral inhibition (BI)
    • Temperamental tendency to be easily distressed by novelty; overlaps with neuroticism & introversion.
    • Infants high in BI → more shyness, avoidance; by adolescence, elevated risk for social anxiety disorder.
    • Longitudinal data (Hayward et al., 1998; Taddon et al., 1997): Children rated high on BI at ages 262{-}6 were more likely to be diagnosed with social anxiety in middle childhood (22 % vs. 8 %).
  • Genetics
    • Twin/genetic studies = modest heritability; estimates h20.120.30h^{2}\approx 0.12{-}0.30.
    • The majority of variance stems from non-shared environmental factors, dovetailing with learning findings.

Treatment Approaches

  • Exposure-based behavioral therapy
    • Graduated (step-wise) exposure to feared social situations; parallels specific-phobia treatment.
  • Cognitive restructuring (part of CBT)
    • Identify automatic negative thoughts ("I have nothing interesting to say", "Everyone will think I’m stupid").
    • Use logical re-analysis questions:
    • “Do I know for certain I will have nothing to contribute?”
    • “Does visible nervousness necessarily lead to rejection?”
    • Goal: Replace distorted appraisals with balanced cognitions.
  • Efficacy
    • CBT (exposure + cognitive restructuring) often outperforms pharmacotherapy and yields longer-lasting gains with low relapse.
    • Clients may continue to improve post-treatment.
  • Pharmacotherapy
    • Antidepressants (MAOIs, SSRIs, SNRIs) can reduce symptoms.
    • Require long-term use to prevent relapse; overall effect sizes often smaller vs. modern CBT protocols.
  • Augmentation strategies
    • Adding social-skills training or assertiveness training can accelerate and potentiate gains.
    • Combining pharmacotherapy with CBT sometimes helpful, but CBT alone usually suffices.

Practical, Ethical, & Societal Considerations

  • Ethical: Clinicians must differentiate culturally normative shyness from clinically impairing social anxiety to avoid pathologizing introversion or cultural restraint.
  • Philosophical: The network-symptom viewpoint challenges categorical diagnosis; encourages a dimensional, mechanistic understanding (e.g., anxiety ↔ alcohol use feedback loops).
  • Public-health relevance: Given early onset, persistence, and functional impairment, early identification (e.g., screening shy/inhibited children) and school-based interventions may lessen lifelong burden.